# US 2025/0177608 A1 · Coating formulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0177608 A1
- Document ID: US20250177608A1
- Status: Published application
- Kind: A1
- Application number: 18/845,151
- Filed: 2023-03-10
- Published: 2025-06-05
- Earliest claimed: 2022-03-10
- Assignees: Ruhr-University Bochum
- Applicants: Ruhr University Bochum
- Inventors: Kenneth Wiliam DALGARNO; Alexander SIEBERATH; Piergiorgio GENTILE; Ana FERREIRA-DUARTE
- Web page: https://patentgrep.com/patent/US20250177608A1

## CPC

- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/34: Macromolecular materials
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61K 33/42: Phosphorus; Compounds thereof
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A61L 27/32: Phosphorus-containing materials, e.g. apatite
- A61L 27/36: containing ingredients of undetermined constitution or reaction products thereof {, e.g. transplant tissue, natural bone, extracellular matrix (isolated natural compounds, e.g. collagen A61L27/24)}
- C12N 5/0654: {Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth}
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61L 2420/02: Methods for coating medical devices
- A61L 2420/08: Coatings comprising two or more layers
- C12N 2506/1346: from mesenchymal stem cells
- C12N 2533/18: Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells
- C12N 2533/54: Collagen; Gelatin
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to formulations, comprising SBF and collagen, and methods that form a bone-like coating on the surface of a substrate. These coated substrates can be used in cell culture experiments to investigate the bone remodelling process and to evaluate drugs for diseases related to bone remodelling, e.g. osteoporosis.

## Claims

### Claim at position 1

1-32. (canceled)

### Claim 33

A coating formulation comprising simulated body fluid (SBF) and collagen, wherein the concentration of Ca2+ in the formulation is >12.5 mM and the concentration of HPO42− in the formulation is >5.0 mM.

### Claim 34 (depends on 33)

The formulation according to claim 33, wherein the concentration of Ca2+ in the formulation is ≥18.8 mM and the concentration of HPO42− in the formulation is ≥7.5 mM.

### Claim 35 (depends on 33)

The formulation according to claim 33, wherein the concentration of collagen in the formulation is in the range from 0.1 mg/ml to 5.0 mg/mL.

### Claim 36 (depends on 35)

The formulation according to claim 35, wherein the concentration of collagen in the formulation is in the range from 0.25 mg/ml to 0.45 mg/mL.

### Claim 37 (depends on 33)

The formulation according to claim 33, wherein the pH of the formulation is in the range from 6.1 to 6.6.

### Claim 38 (depends on 37)

The formulation according to claim 37, wherein the pH of the formulation is in the range from 6.25 to 6.30.

### Claim 39 (depends on 33)

The formulation according to claim 33, wherein the formulation further comprises sodium bicarbonate.

### Claim 40 (depends on 33)

A method for depositing a bone-like coating onto a substrate, the method comprising step c):
c) contacting the substrate with a coating formulation according to claim 33 to form a coated substrate.

### Claim 41 (depends on 40)

The method according to claim 40, wherein the method further comprises steps a) and b):
a) adding collagen to the simulated body fluid (SBF), wherein the concentration of Ca2+ in the SBF is >12.5 mM and the concentration of HPO42− in the SBF is >5.0 mM, to form an intermediate formulation; and
b) adjusting the pH of the intermediate formulation to be in the range from 6.1 to 6.6 to form the coating formulation.

### Claim 42 (depends on 41)

The method according to claim 41, wherein the concentration of collagen in the collagen solution is in the range from 4 mg/ml to 8 mg/mL.

### Claim 43 (depends on 41)

The method according to claim 41, wherein step b) further comprises adjusting the pH of the intermediate formulation to be in the range from 6.25 to 6.30.

### Claim 44 (depends on 41)

The method according to claim 41, wherein step b) further comprises adding sodium bicarbonate to the intermediate formulation.

### Claim 45 (depends on 41)

The method according to claim 41, wherein the concentration of Ca2+ in the SBF is ≥18.8 mM and the concentration of HPO42− in the SBF is ≥7.5 mM.

### Claim 46 (depends on 41)

The method according to claim 41, wherein the pH of the SBF is in the range from 6.1 to 6.6.

### Claim 47 (depends on 40)

The method according to claim 40, wherein the substrate is a metal substrate.

### Claim 48 (depends on 40)

The method according to claim 40, wherein the substrate is a polymer substrate.

### Claim 49 (depends on 48)

The method according to claim 48, wherein the substrate is a cell culture plate.

### Claim 50 (depends on 40)

The method according to claim 40, wherein the substrate is a 3D printed object and/or a medical implant.

### Claim 51 (depends on 40)

The method according to claim 40, wherein the method further comprises step d): incubating the coated substrate in a basal medium for at least 6 hours.

### Claim 52 (depends on 40)

A method comprising steps i), ii) and iv):
i) carrying out a method according to claim 40 to form a coated substrate;
ii) culturing cells on the coated substrate to form a cell culture; and
iv) monitoring the bone-like coating and/or bone remodeling activity of the cell culture.

### Claim 53 (depends on 52)

The method according to claim 52, wherein the cells comprise osteoclasts and, optionally, osteoblasts.

### Claim 54 (depends on 52)

The method according to claim 52, wherein step iv) further comprises assessing the resorption of the bone-like coating and the formation of bone.

### Claim 55 (depends on 42)

The method according to claim 42, wherein the method further comprises fluorescently labelling the bone-like coating.

### Claim 56 (depends on 55)

The method according to claim 55, wherein step iv) further comprises monitoring the fluorescence of the bone-like coating and/or the cell culture.

### Claim 57 (depends on 52)

The method according to claim 52, wherein the method is a method for assaying a pharmaceutical compound, and wherein the method further comprises step iii): contacting the cell culture with a pharmaceutical compound.

### Claim 58

A kit comprising:
simulated body fluid (SBF), wherein the concentration of Ca2+ in the SBF is >12.5 mM and the concentration of HPO42− in the SBF is >5.0 mM; and
a collagen solution.

### Claim 59 (depends on 58)

The kit according to claim 58, wherein the concentration of Ca2+ in the SBF is ≥18.8 mM and the concentration of HPO42− in the SBF is ≥7.5 mM.

### Claim 60 (depends on 58)

The kit according to claim 58, wherein the concentration of collagen in the collagen solution is in the range from 4 mg/ml to 8 mg/mL.

### Claim 61 (depends on 58)

The kit according to claim 58, wherein the kit further comprises sodium bicarbonate.

### Claim 62

A coated substrate, comprising:
a substrate; and
a coating on the substrate, wherein the coating comprises calcium phosphate at the interface between the substrate and coating and collagen deposited on the calcium phosphate.

### Claim 63 (depends on 40)

A coated substrate obtained by a method according to claim 40.
